Skip to content
Aperlena

Poland - Pharmaceutical products - Supply of medicines used in oncological drug programmes

Original Polska - Produkty farmaceutyczne - Dostawa leków stosowanych w programach lekowych onkologicznych

Open Contract notice 5 days left
Watch this tender

Deadline 30 Sep. If it moves, an email when the register sees it. A correction: the same email. Log in

  1. Published
  2. Today
  3. Deadline open for 30 days
  4. Awarded pending

The Aperlena Verdict

Open race

No supplier dominates: 61 different companies have won the last 66 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Based on 66 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

This Polish public tender covers the supply of medicines used in oncological drug programmes, divided into 25 assortment tasks. The products include a range of oncology medicines such as abemaciclib, apalutamide, atezolizumab, avelumab, bevacizumab, cabozantinib, dabrafenib, darolutamide, durvalumab, enzalutamide, ipilimumab, niraparib, nivolumab, olaparib, osimertinib, palbociclib, pembrolizumab, pertuzumab, ramucirumab, ribociclib, talazoparib, trametinib, trastuzumab deruxtecan, trastuzumab emtansine and trifluridine with tipiracil hydrochloride.

Description

Dostawa leków stosowanych w programach lekowych onkologicznych - 25 zadań asortymentowych Abemaciclibum - 3 pozycje asortymentowe; Apalutamidum - 1 pozycja asortymentowa; Atezolizumab - 1 pozycja asortymentowa; Avelumab - 1 pozycja asortymentowa; Bevacizumab - 1 pozycja asortymentowa; Cabozantinibum - 2 pozycje asortymentowe; Dabrafenibum - 2 pozycje asortymentowe; Darolutamidum - 1 pozycja asortymentowa; Durvalumabum - 1 pozycja asortymentowa; Enzalutamidum - 1 pozycja asortymentowa; Ipilimumabum - 2 pozycje asortymentowe; Niraparib - 1 pozycja asortymentowa; Nivolumab - 1 pozycja asortymentowa; Olaparib - 2 pozycje asortymentowe; Osimertinib - 2 pozycje asortymentowe; Palbociclib - 3 pozycje asortymentowe; Pembrolizumab - 1 pozycja asortymentowa; Pertuzumab - 1 pozycja asortymentowa; Ramucirumab - 1 pozycja asortymentowa; Ribociclibum - 1 pozycja asortymentowa; Talazoparib - 1 pozycja asortymentowa; Trametinibum - 2 pozycje asortymentowe; Trastuzumab deruxtecan - 1 pozycja asortymentowa; Trastuzumab emtansine - 1 pozycja asortymentowa; Trifluridine, Tipiracil hydrochloride - 2 pozycje asortymentowe

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 weeks ago

More from this buyer

Full buyer profile

7 open tenders right now

Who usually wins this buyer's contracts in this sector

Based on 66 awards with a linked company profile over the last 5 years.

What this buyer has paid before

Based on 45 comparable contracts this buyer awarded in this sector over the last 4 years.

€53,011
Lower quartile
€259,488
Median award
€463,834
Upper quartile

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,214,847
9,859 open across Europe right now
Buyer track record on Aperlena
216 notices tracked · 116 awarded
€51,350,469 in awarded contracts

Never miss a tender like this

920 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close